Renaissance Technologies's ABBV Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 0 shares of AbbVie Inc. (ABBV) worth $0, representing 0.00% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 51 quarters.
Based on 13F filings since 2013, Renaissance Technologies has maintained a long-term strategic position in ABBV, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2020, adding 5.47 M shares. Largest reduction occurred in Q4 2020, reducing 7.41 M shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's AbbVie (ABBV) Holding Value Over Time
Track share changes against reported price movement
Quarterly AbbVie (ABBV) Trades by Renaissance Technologies
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -928,071 | Sold Out | 0 | $0.00 |
| Q3 2025 | -1.03 M | Reduce 52.70% | 928,071 | $231.54 |
| Q2 2025 | +739,900 | Add 60.54% | 1.96 M | $185.62 |
| Q1 2025 | +249,204 | Add 25.61% | 1.22 M | $209.52 |
| Q4 2024 | -164,677 | Reduce 14.48% | 972,894 | $177.70 |
| Q3 2024 | -167,100 | Reduce 12.81% | 1.14 M | $197.48 |
| Q2 2024 | +175,677 | Add 15.56% | 1.3 M | $171.52 |
| Q1 2024 | -867,717 | Reduce 43.46% | 1.13 M | $182.10 |
| Q4 2023 | +638,612 | Add 47.02% | 2 M | $154.97 |
| Q3 2023 | +70,991 | Add 5.52% | 1.36 M | $149.06 |
| Q2 2023 | +964,212 | Add 298.61% | 1.29 M | $0.13 |
| Q1 2023 | -15,900 | Reduce 4.69% | 322,896 | $0.16 |
| Q4 2022 | -26,606 | Reduce 7.28% | 338,796 | $0.16 |
| Q3 2022 | -985,578 | Reduce 72.95% | 365,402 | $134.21 |
| Q2 2022 | +427,677 | Add 46.32% | 1.35 M | $153.16 |
| Q1 2022 | -1.13 M | Reduce 55.04% | 923,303 | $162.11 |
| Q4 2021 | -17,317 | Reduce 0.84% | 2.05 M | $135.40 |
| Q3 2021 | +1.34 M | Add 183.71% | 2.07 M | $107.87 |
| Q2 2021 | -117,113 | Reduce 13.83% | 729,924 | $112.64 |
| Q1 2021 | -5.22 M | Reduce 86.03% | 847,037 | $108.22 |
| Q4 2020 | -7.41 M | Reduce 54.99% | 6.06 M | $107.15 |
| Q3 2020 | -5.55 M | Reduce 29.18% | 13.47 M | $87.59 |
| Q2 2020 | +5.47 M | Add 40.32% | 19.02 M | $98.18 |
| Q1 2020 | +1.76 M | Add 14.91% | 13.56 M | $76.19 |
| Q4 2019 | +4.49 M | Add 61.45% | 11.8 M | $88.54 |
| Q3 2019 | +2.77 M | Add 60.99% | 7.31 M | $75.72 |
| Q2 2019 | +2.06 M | Add 83.45% | 4.54 M | $72.72 |
| Q1 2019 | +2.37 M | Add 2386.49% | 2.47 M | $80.59 |
| Q4 2018 | -1.12 M | Reduce 91.84% | 99,500 | $92.19 |
| Q3 2018 | -1.14 M | Reduce 48.35% | 1.22 M | $94.58 |
| Q2 2018 | +606,627 | Add 34.55% | 2.36 M | $92.65 |
| Q1 2018 | +1.76 M | New Buy | 1.76 M | $94.65 |
| Q4 2017 | -1.41 M | Sold Out | 0 | $0.00 |
| Q3 2017 | -1.81 M | Reduce 56.28% | 1.41 M | $88.86 |
| Q2 2017 | +1.13 M | Add 54.23% | 3.22 M | $72.51 |
| Q1 2017 | +1.74 M | Add 495.20% | 2.09 M | $65.16 |
| Q4 2016 | -1.57 M | Reduce 81.71% | 350,800 | $62.62 |
| Q3 2016 | +700,856 | Add 57.56% | 1.92 M | $63.07 |
| Q2 2016 | -345,456 | Reduce 22.10% | 1.22 M | $61.91 |
| Q1 2016 | +980,300 | Add 168.22% | 1.56 M | $57.12 |
| Q4 2015 | -2.35 M | Reduce 80.14% | 582,756 | $59.24 |
| Q3 2015 | +2.93 M | Add 35677.51% | 2.93 M | $54.41 |
| Q2 2015 | -1.18 M | Reduce 99.31% | 8,200 | $67.20 |
| Q1 2015 | +970,497 | Add 445.39% | 1.19 M | $58.54 |
| Q4 2014 | -504,455 | Reduce 69.83% | 217,900 | $65.44 |
| Q3 2014 | -1.51 M | Reduce 67.66% | 722,355 | $57.76 |
| Q2 2014 | -563,300 | Reduce 20.14% | 2.23 M | $56.44 |
| Q1 2014 | +987,300 | Add 54.56% | 2.8 M | $51.40 |
| Q4 2013 | -181,900 | Reduce 9.13% | 1.81 M | $52.81 |
| Q3 2013 | +1.45 M | Add 268.59% | 1.99 M | $44.73 |
| Q2 2013 | +540,300 | Add 0.00% | 540,300 | $41.34 |
Renaissance Technologies's AbbVie Investment FAQs
Renaissance Technologies first purchased AbbVie Inc. (ABBV) in Q2 2013, acquiring 540,300 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies has held AbbVie Inc. (ABBV) for 51 quarters since Q2 2013.
Renaissance Technologies's largest addition to AbbVie Inc. (ABBV) was in Q2 2020, adding 19,021,869 shares worth $1.87 B.
According to the latest 13F filing for Q4 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 0 shares of AbbVie Inc. (ABBV), valued at approximately $0.
As of the Q4 2025 filing, AbbVie Inc. (ABBV) represents approximately 0.00% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies's peak holding in AbbVie Inc. (ABBV) was 19,021,869 shares, as reported at the end of Q2 2020.